Delivery Order SPE2DB22D3301-SPE2DB25FY0HP

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,070.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567130613 - Lidocaine 2% Viscous Solution 100ML, a medical product used in various healthcare settings. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 4, 2025. It is not designated as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,965.74 firm fixed-price delivery order contract is for the provision of 100 ml bottles of 2% lidocaine viscous solution. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, valued at $2,419.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 2% Viscous Solution, a pharmaceutical product, to support military and federal healthcare programs. The contract has an ultimate completion date of November 17, 2023, and is a Firm Fixed Price Delivery Order. The award is associated with a larger...
This federal contract award, valued at $2,823.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lidocaine 2% Viscous Solution in 100ml containers, a medical product used for various healthcare applications. The contract is a firm fixed-price delivery order with a period of performance through March 2024. This award is part of Amerisourcebergen's broader...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,849.16 firm fixed price contract is for the delivery of 100 ml bottles of 2% lidocaine viscous solution to support military treatment programs and facilities. The delivery order does not have a set-aside designation and is being issued under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 1, 2024. The contract is a Delivery Order valued at $1,437.58 for the supply of a 4% Lidocaine HCL solution, with a period of performance through November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,767.27, is for the delivery of 4564203887 - Lidocaine 2% Viscous 15 ML Cup UD 15ML. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $11,154.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 2% Viscous Solution in 100ml bottles. It is a Firm Fixed Price Delivery Order contract with a completion date of December 14, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FP5Q4) valued at $1,628.10 for the supply of Lidocaine HCL 2% in 5 mL vials. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of August 30, 2023 and is a firm fixed price agreement. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $50,251.30, is for the delivery of Lidocaine 2% Viscous Solution, a medical product, to support various government agencies and healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp has been awarded...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY0HP
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 2% viscous solution in 100ml quantities. The $2,178.33 firm fixed price Delivery Order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:12 AM